Germantown, MD, United States of America

Richard Smith


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Richard Smith: A Pioneer in Gene Therapy

Introduction: Richard Smith, based in Germantown, MD, has made significant contributions to the field of gene therapy through his pioneering work in adeno-associated virus (AAV) technologies. With a strong focus on polynucleotides and polypeptides, Smith’s innovations are crucial for advancing medical treatments.

Latest Patents: Smith holds a patent for "Adeno-associated virus polynucleotides, polypeptides and virions." This patent focuses on polypeptides encoded by an AAV-derived endogenous viral element (mAAV-EVE1) found within the germline of closely related marsupial species. Key elements of this invention include nucleic acid molecules that encode the polypeptides, vectors containing these nucleic acids, and recombinant AAV virions that incorporate the polypeptides. Furthermore, his work includes the development of a chimeric capsid protein that also features an MAAV-EVE1 polypeptide.

Career Highlights: Richard Smith has built a notable career working with prominent research institutions. He has been associated with the Children’s Medical Research Institute and The Sydney Children’s Hospitals Network, specifically at Randwick and Westmead, which includes the Royal Alexandra Hospital for Children. His innovative research in gene therapy has laid the foundation for advancements in treatment methodologies, particularly in pediatric medicine.

Collaborations: Throughout his career, Smith has collaborated with esteemed colleagues such as Claus Hallwirth and Ian Alexander. These partnerships have enhanced his research output and have played a significant role in the development of his patented technologies.

Conclusion: Richard Smith’s contributions to the field of gene therapy through his innovative patents and collaborations with leading medical institutions mark him as a key figure in the realm of biotechnology. His work continues to inspire advancements in therapeutic applications and illustrates the profound impact of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…